WO1999025718A1 - DERIVES DE 5H-PYRANO[2,3-d:6,5-d']DIPYRIMIDINE AYANT UNE ACTION ANTIBACTERIENNE, ANTIVIRALE ET IMMUNO-MODULATRICE - Google Patents
DERIVES DE 5H-PYRANO[2,3-d:6,5-d']DIPYRIMIDINE AYANT UNE ACTION ANTIBACTERIENNE, ANTIVIRALE ET IMMUNO-MODULATRICEInfo
- Publication number
- WO1999025718A1 WO1999025718A1 PCT/RU1997/000371 RU9700371W WO9925718A1 WO 1999025718 A1 WO1999025718 A1 WO 1999025718A1 RU 9700371 W RU9700371 W RU 9700371W WO 9925718 A1 WO9925718 A1 WO 9925718A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- νοι
- substances
- synthesis
- dipyrimidine
- activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Definitions
- New nimirimidine derivatives are biologically active substances.
- i ⁇ is ⁇ lzuyu ⁇ sya ⁇ a ⁇ ⁇ a ⁇ matsev ⁇ iches ⁇ ie ⁇ e ⁇ a ⁇ a ⁇ y, ⁇ bladayuschie sn ⁇ v ⁇ nym, ⁇ iv ⁇ sud ⁇ zhnym (ba ⁇ bi ⁇ u ⁇ a ⁇ y, ge ⁇ samidin, benz ⁇ nal) diu ⁇ e ⁇ iches ⁇ im (me ⁇ uzal) ⁇ iv ⁇ v ⁇ s ⁇ ali ⁇ elnym ( pentoxyl, methyla
- the invention i.e.
- the objective of the invention is the creation of new substances that are equipped with convenient, convenient, immuno-modulating and nonpractical activity.
- ⁇ 1 is selected from the group GID ⁇ SIG ⁇ UPP, ⁇ P ⁇ G ⁇ UPP, G ⁇ L ⁇ G ⁇ ,
- ⁇ , G 2 is selected from the group HID ⁇ SIG ⁇ UPP, ⁇ L ⁇ SIG ⁇ UPP,
- Part 3 is selected from the group ⁇ ⁇ , ⁇ , and the best options for declared substances are .
- ⁇ 1 It should be noted at once that the use of other distributors of alcohol, drugs, phytogenesis and aromatic disease does not have any harm the essential elements are not the specific elements of the radicals ⁇ 1 , ⁇ 2, and, 3 , and their property is mentioned in the general group formula. The proposed best options are presented for visualization in the below table format.
- Example 1 a variant of the synthesis - 5-
- EXAMPLE 2 a variant of the synthesis of 5- Sprint ⁇ yl - 2,4,6,8-tetrahydroxy-5Ya-pyrano- ( ⁇ , ⁇ , ⁇ , ⁇ , ⁇ ) and 5-aryl-4,6-dihydride-oxy-2,8-dimer ⁇ -5 ⁇ -pyrene [2,3-sec /: 6,5- demander ⁇ ] dipirimidine )
- EXAMPLE 3 A variant of the synthesis of 2,4,6,8-Methahydroxy-5- (g7-nitrophenyl) - 5 ⁇ -pyrene [2,3-s /: 6,5-sH] dipyrimidine (I).
- Example 4 is a variant of the synthesis of 5P-phenyl-2,4,6,8-tetra-5-pyr [2,3- s: 6,5-cG] dipyrimidine.
- Example 5 is a variant of the synthesis of 2,8-dihydroxy-4,6-dimethoxy-5- (4-nitro-phenyl) -5 / ⁇ -pyrene [2,3-c: 6,5-cg] dipyrimidine ( ⁇ ).
- EXAMPLE 6 is the best known variant of the synthesis to 4,6-dihydrogen-psi-2,8-dimerpacto-5- (l-nitrphenyl) -5 ⁇ -pyrene [2,3-s /: 6,5-sg] di-pyr- midine (IX).
- EXAMPLE 7 is the best known variant of the synthesis of 5-phenyl-2,4,6,8-tetra-5-phenyl [2,3 - ⁇ /: 6,5-cg] dipyrimidine (II)
- Example 8 is the best known variant of the synthesis of 2,8-dihydroxy-4,6-dimethoxy-5- (4-nitrophenyl) -5 ⁇ -pyrpheno [2,3-s: 6,5-cG] dipyrimidine
- Table 3 outputs, distribution temperatures and elemental analysis of the claimed substances - 5 ⁇ -Pyrano [2,3-sec /: 6,5- ⁇ "] experiment 1 (with table 4) - distribution;
- EXPERIMENT 4 (with Table 7) is a division of the toxicity of the claimed substances.
- a mixture of 3 mmol of pyridinium salt of 5,5-arylidenebis (2-th) barbic acid and 55 mm of S3 3 is heated while stirring to boil. After dissolving the precipitate (after ⁇ 1 h), the solution adds 3.5 mmol ⁇ 2 ⁇ 5 . Stir the mixing mixture for 5-7 hours, and then pour it into 150-200 ml of cold water and leave it overnight. If the sediment is found, it is filtered, washed with ethanol or acetone, and it is removed from the water. ⁇ regulate 20-30%. For example, 2.
- Example 6 The best variant of the synthesis is 4,6-dihydrooxi-2,8-dimerpactapo-5- (l-nitropo-phenyl) -5 ⁇ -pyrene [2,3-c /: 6,5-cg] dipyrimidine (IX) .
- Example 7 The best variant of the synthesis of 5-phenyl-2,4,6,8-tetra-5 ⁇ -pyr [2,3-c /: 6.5-cG] dipyrimidine ( ⁇ ).
- EXAMPLE 8 The best variant of the synthesis is 2,8-dihydroxy-4,6-dimethoxy-5- (4-nitro-phenyl) -5 ⁇ -pyrene [2,3-c /: 6,5-cg] dipyrimidine (V) .
- Dispositions and elemental analysis of the claimed substances are 5J-pyrrhene [2,3-s /: 6,5-s ⁇ dipirimidine.
- Antiviral activity was studied in relation to the virus of the herpes type I type
- the results were evaluated by the presence of the cytotropic effect of the virus on the cells after 36 hours of incubation at 38 ° C in the S ⁇ 2-incubator.
- the distributor (DSC) is toxic.
- the induction of the synthesis of substances by the claimed preparations was made on the human culture of human persons (the name of the data in the case of human beings is an injury to people).
- To receive the culture of lymphomas we used a fresh (12 hours after the fence) access to the health of the donors (not the second group).
- the patient’s acquired area, obtained from a healthy patient was subject to centrifugal treatment of the patient with a patient's immune status 1. ⁇ / ⁇ 7 / 00371
- the indicated fraction was removed and diluted with ' healthy medium ⁇ -1640, containing a 5% fetal serum content of 100 ml, 50 mg / ml, The concentration of licenses was taken into account after scraping with methyl blue and the number of cells in the camera Goryaeva.
- the inventories of the claimed substances diluted the healthy medium ⁇ -1640, so that the final concentrations of the substances amounted to 100 mg / l, 10 mg / l, 1 mg / l.
- the final concentration of lymphocytes in the industrial mixture was 3 * 106 cells / ml.
- the following controls were delivered:
- the method used a solid immunodeficiency method with the use of the conversion of oxidase in the form of an indicator of the disease.
- the efficiency of the coupled oxidase was measured using an automatic device for the microplate with a microprocessor with a wavelength of 450 nm.
- the reactive activity of the claimed compounds was studied in connection with S.GasItauz 0323, the standard strain from the collection of the social security system of the United States a ⁇ . I.P. Pavlova. This strain was distinguished from a chlamydial disorder, had a mild and physiological activity, and was physically safe for the treatment of the patient.
- ⁇ n ⁇ li v ⁇ lyuchali ⁇ n ⁇ li ⁇ ul ⁇ u ⁇ ⁇ le ⁇ , ⁇ n ⁇ l deys ⁇ viya ⁇ as ⁇ v ⁇ i ⁇ eley, ⁇ n ⁇ l deys ⁇ viya ⁇ lamidy in ⁇ su ⁇ s ⁇ vii to- ⁇ ⁇ a ⁇ i ⁇ no byl ⁇ ⁇ e ⁇ a ⁇ a ⁇ v, ⁇ n ⁇ l chuvs ⁇ vi ⁇ eln ⁇ s ⁇ i ⁇ lamidy ⁇ s ⁇ anda ⁇ nym an ⁇ imi ⁇ bnym ⁇ e ⁇ a ⁇ a ⁇ am - tsi ⁇ l ⁇ satsinu and aba ⁇ alu [46], ⁇ n ⁇ l is ⁇ y ⁇ uemy ⁇ s ⁇ edineny on ⁇ sichn ⁇ s ⁇ ⁇ ⁇ n ⁇ sheniyu ⁇ ⁇ ul ⁇ u ⁇ am ⁇ le ⁇ .
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL13618197A IL136181A0 (en) | 1997-11-19 | 1997-11-19 | 5H-PYRANO[2,3-d:6,5-d'] DIPYRIMIDINE DERIVATIVES HAVING AN ANTIBACTERIAL, ANTIVIRAL, AND IMMUNO-MODULATING ACTIVITY |
CA002310398A CA2310398C (en) | 1997-11-19 | 1997-11-19 | 5h-pyrano[2,3-d:6,5-d']dipyrimidine derivatives having an antibacterial, antiviral and immuno-modulating activity |
US09/554,836 US6340755B1 (en) | 1997-11-19 | 1997-11-19 | 5H-Pyrano[2,3-d: 6,5-d']dipyrimidine derivatives having an antibacterial, antiviral and immuno-modulating activity |
AU61257/98A AU739701B2 (en) | 1997-11-19 | 1997-11-19 | 5h-pyrano(2,3-d:6,5-d')dipyrimidine derivatives having an antibacterial, antiviral and immunomodulating activity |
AT97954962T ATE231868T1 (de) | 1997-11-19 | 1997-11-19 | 5h-pyrano(2,3-d:6,5-d')dipyrimidin-derivate mit antibakterieller, antiviraler und immunmodulatorischer wirkung |
DE69718831T DE69718831T2 (de) | 1997-11-19 | 1997-11-19 | 5h-pyrano[2,3-d:6,5-d']dipyrimidin-derivate mit antibakterieller, antiviraler und immunmodulatorischer wirkung |
JP2000521099A JP2001523683A (ja) | 1997-11-19 | 1997-11-19 | 抗菌、抗ウイルス及び免疫調節作用を有する5H−ピラノ[2,3−d:6,5d’]ジピリミジン誘導体 |
PCT/RU1997/000371 WO1999025718A1 (fr) | 1997-11-19 | 1997-11-19 | DERIVES DE 5H-PYRANO[2,3-d:6,5-d']DIPYRIMIDINE AYANT UNE ACTION ANTIBACTERIENNE, ANTIVIRALE ET IMMUNO-MODULATRICE |
EP97954962A EP1033369B1 (en) | 1997-11-19 | 1997-11-19 | 5H-PYRANO [2,3-d:6,5-d']DIPYRIMIDINE DERIVATIVES HAVING AN ANTIBACTERIAL, ANTIVIRAL AND IMMUNO-MODULATING ACTIVITY |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/RU1997/000371 WO1999025718A1 (fr) | 1997-11-19 | 1997-11-19 | DERIVES DE 5H-PYRANO[2,3-d:6,5-d']DIPYRIMIDINE AYANT UNE ACTION ANTIBACTERIENNE, ANTIVIRALE ET IMMUNO-MODULATRICE |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999025718A1 true WO1999025718A1 (fr) | 1999-05-27 |
Family
ID=20130165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/RU1997/000371 WO1999025718A1 (fr) | 1997-11-19 | 1997-11-19 | DERIVES DE 5H-PYRANO[2,3-d:6,5-d']DIPYRIMIDINE AYANT UNE ACTION ANTIBACTERIENNE, ANTIVIRALE ET IMMUNO-MODULATRICE |
Country Status (9)
Country | Link |
---|---|
US (1) | US6340755B1 (ru) |
EP (1) | EP1033369B1 (ru) |
JP (1) | JP2001523683A (ru) |
AT (1) | ATE231868T1 (ru) |
AU (1) | AU739701B2 (ru) |
CA (1) | CA2310398C (ru) |
DE (1) | DE69718831T2 (ru) |
IL (1) | IL136181A0 (ru) |
WO (1) | WO1999025718A1 (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002003971A2 (en) * | 2000-07-07 | 2002-01-17 | Stichting Rega Vzw | Pharmaceutical composition and method for the treatment of retroviral infections |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0016845D0 (en) * | 2000-07-07 | 2000-08-30 | Leuven K U Res & Dev | Pharmaceutical composition for treatment of HIV infection |
RU2246496C1 (ru) * | 2003-09-12 | 2005-02-20 | Тец Виктор Вениаминович | Вещество с противовирусной и антибактериальной активностью на основе производных 2,8-дитиоксо-1h-пирано[2,3-d, 6,5-d`] дипиримидина и их 10-аза-аналогов |
RU2595038C1 (ru) * | 2015-04-03 | 2016-08-20 | Виктор Вениаминович Тец | Лекарственное средство с противовирусной активностью (варианты) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU487076A1 (ru) * | 1974-05-17 | 1975-10-05 | Киевский Ордена Ленина Государственный Университет Им.Т.Г. Шевченко | Способ получени солей производных пирилиа (2,3- ) пиримидина |
US4272535A (en) * | 1978-07-31 | 1981-06-09 | Schering Corporation | 2,4-[1H,3H,5H]-(1)-Benzopyrano-[2,3-d]-pyrimidinediones and their use as anti-allergy agents |
US4297355A (en) * | 1979-11-15 | 1981-10-27 | Schering Corporation | (1H,3H,5H)-(1)-Benzopyrano-(2,3-d)-pyrimidine-4-one-2-thiones and their use as anti-allergy agents |
US4578380A (en) * | 1983-09-30 | 1986-03-25 | Warner-Lambert Company | 5H-[1]benzopyrano[2,3-d]pyrimidine derivatives useful for controlling lesions of the gastric and duodenal mucous membranes |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH485972A (fr) | 1968-11-01 | 1970-02-15 | Lucifer Sa | Valve servo-commandée à piston |
IE49570B1 (en) | 1979-03-30 | 1985-10-30 | Rhone Poulenc Ind | 2-(pyrid-2-yl)tetrahydrothiophene derivatives |
US5639881A (en) | 1991-11-08 | 1997-06-17 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Synthesis and elucidation of pyrimido (4,5-Q) quinazoline derivatives |
DE19502179A1 (de) * | 1995-01-25 | 1996-08-01 | Thomae Gmbh Dr K | Trisubstituierte Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
-
1997
- 1997-11-19 IL IL13618197A patent/IL136181A0/xx unknown
- 1997-11-19 AU AU61257/98A patent/AU739701B2/en not_active Ceased
- 1997-11-19 WO PCT/RU1997/000371 patent/WO1999025718A1/ru active IP Right Grant
- 1997-11-19 AT AT97954962T patent/ATE231868T1/de not_active IP Right Cessation
- 1997-11-19 EP EP97954962A patent/EP1033369B1/en not_active Expired - Lifetime
- 1997-11-19 JP JP2000521099A patent/JP2001523683A/ja not_active Ceased
- 1997-11-19 US US09/554,836 patent/US6340755B1/en not_active Expired - Fee Related
- 1997-11-19 CA CA002310398A patent/CA2310398C/en not_active Expired - Fee Related
- 1997-11-19 DE DE69718831T patent/DE69718831T2/de not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU487076A1 (ru) * | 1974-05-17 | 1975-10-05 | Киевский Ордена Ленина Государственный Университет Им.Т.Г. Шевченко | Способ получени солей производных пирилиа (2,3- ) пиримидина |
US4272535A (en) * | 1978-07-31 | 1981-06-09 | Schering Corporation | 2,4-[1H,3H,5H]-(1)-Benzopyrano-[2,3-d]-pyrimidinediones and their use as anti-allergy agents |
US4297355A (en) * | 1979-11-15 | 1981-10-27 | Schering Corporation | (1H,3H,5H)-(1)-Benzopyrano-(2,3-d)-pyrimidine-4-one-2-thiones and their use as anti-allergy agents |
US4578380A (en) * | 1983-09-30 | 1986-03-25 | Warner-Lambert Company | 5H-[1]benzopyrano[2,3-d]pyrimidine derivatives useful for controlling lesions of the gastric and duodenal mucous membranes |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002003971A2 (en) * | 2000-07-07 | 2002-01-17 | Stichting Rega Vzw | Pharmaceutical composition and method for the treatment of retroviral infections |
WO2002003971A3 (en) * | 2000-07-07 | 2002-05-16 | Stichting Rega V Z W | Pharmaceutical composition and method for the treatment of retroviral infections |
Also Published As
Publication number | Publication date |
---|---|
AU6125798A (en) | 1999-06-07 |
JP2001523683A (ja) | 2001-11-27 |
ATE231868T1 (de) | 2003-02-15 |
IL136181A0 (en) | 2001-05-20 |
EP1033369B1 (en) | 2003-01-29 |
US6340755B1 (en) | 2002-01-22 |
CA2310398A1 (en) | 1999-05-27 |
DE69718831T2 (de) | 2003-08-14 |
EP1033369A1 (en) | 2000-09-06 |
AU739701B2 (en) | 2001-10-18 |
DE69718831D1 (de) | 2003-03-06 |
CA2310398C (en) | 2006-10-24 |
EP1033369A4 (en) | 2001-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999001103A2 (fr) | Derives de peptides, sels de ces derives acceptables sur le plan pharmaceutique, procede de production de ces derives, utilisation de ces derniers et composition pharmaceutique | |
WO1999061427A1 (fr) | Derives n-substitues d'acide 5-oxyiminobarbiturique | |
EP1380295A4 (en) | PHOTOSENSITIZER AND PROCESS FOR PRODUCING THE PHOTOSENSITIZER | |
Nery | Some aspects of the metabolism of urethane and N-hydroxyurethane in rodents | |
WO1990008135A1 (en) | Ethyl ester 6-bromine-5-hydroxy-4-dimethyl-aminomethyl-1-methyl-2-phenylthiomethyl indole-3-carboxylic acid hydrochloride monohydrate, method of obtaining it and a pharmaceutical preparation of antiviral, interferon inducing and immunomodulating action based on it | |
CN101370783A (zh) | 9-氧代吖啶-10-乙酸和1-烷基氨基-1-脱氧多羟基化合物的盐和混合物、包含其的药物组合物以及治疗方法 | |
WO1999025718A1 (fr) | DERIVES DE 5H-PYRANO[2,3-d:6,5-d']DIPYRIMIDINE AYANT UNE ACTION ANTIBACTERIENNE, ANTIVIRALE ET IMMUNO-MODULATRICE | |
Philips et al. | Physiologic disposition and intracellular localization of isometamidium | |
IL28164A (en) | Substituted ammonium basic addition salts of ribonucleic acid and their preparation | |
CN103347849B (zh) | 富勒烯с60的均聚氨基酸和杂多氨基酸衍生物、其制备方法和基于该衍生物的药物组合物 | |
JPS61171495A (ja) | 白金錯体類及びその製造方法 | |
Boyland et al. | The biochemistry of aromatic amines. 8. Synthesis and detection of di-(2-amino-1-naphthyl) hydrogen phosphate, a metabolite of 2-naphthylamine in dogs | |
WO1994022837A1 (en) | N-METHYL-N-/α,Δ-GLUCOPYRANOZIL/AMMONIA-2-/ACRIDON-9-ON-10-YL/ACETATE/CYCLOPHERONE, WITH INTERFERON PRODUCING, ANTI-VIRAL (INCLUDING ANTI-HIV), ANTI-PARASITIC, ANTI-PROMOTER AND RADIOPROTECTIVE PROPERTIES | |
WO2005103014A1 (fr) | Sels de 2,4-dioxo-5-(2-hydroxy-3,5-dichloro-benzylidene)imino-1,3-pyrimidine | |
EP1022278A4 (en) | TETRACYCLIC PYRIMIDINE DERIVATIVES | |
RU2487878C1 (ru) | Комплексные соединения германия с производными азотистых оснований пуринового ряда, способы их получения и содержащие их лекарственные средства | |
WO2000034250A1 (fr) | 2,4-dioxo-5-arylidenimino-1,3-pyrimidines | |
WO1999025699A1 (fr) | Sels d'acides 5,5'-arylidenebisbarbituriques et 5,5'-arylidenebis(2-thiobarbituriques) et acides 5,5'-arylidenebis(2-thiobarbituriques) ayant une action antibacterienne, anti-chlamydiose, antivirale et immuno-modulatrice | |
WO2001019801A1 (fr) | Substance bioactive a base de derives des 2-amino-6-aryloxypyrimidines et de produits de synthese intermediaires de ces derniers | |
WO2000034234A1 (fr) | Aryl- et heteroarylamides d'acides carboalcoxysulfaniliques | |
JPS6025969A (ja) | アレルギ−治療用組成物 | |
EP1669357A8 (en) | Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[ 2,3-d,6,5-d'] dipyrimidine and 10-aza-analogue thereof | |
WO2000029389A1 (fr) | 6-(3-carboxymethylphenyl)-amino-uracyle ayant une action biologique | |
WO2000034259A1 (fr) | Derives de 2-r-5-amino-1,3,4-thiadiazole bioactifs | |
CN106397432B (zh) | 作为jak抑制剂的一类化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2310398 Country of ref document: CA Ref country code: CA Ref document number: 2310398 Kind code of ref document: A Format of ref document f/p: F |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1997954962 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 61257/98 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09554836 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1997954962 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 61257/98 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 1997954962 Country of ref document: EP |